Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
24
AIMD Quote, Financials, Valuation and Earnings
Last price:
$1.98
Seasonality move
:
53.39%
Day range:
$1.98 - $2.05
52-week range:
$1.78 - $5.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
174.92x
P/B ratio:
0.83x
Volume:
2.9K
Avg. volume:
32.7K
1-year change:
-15.17%
Market cap:
$8.3M
Revenue:
$20.7K
EPS (TTM):
-$3.35
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Ainos, Inc. has -- downside to fair value with a price target of -- per share.
AIMD vs. S&P 500
-
Over the past 5 trading days, Ainos, Inc. has underperformed the S&P 500 by -7.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ainos, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ainos, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Ainos, Inc. reported revenues of $2.2K.
Earnings Growth
-
Ainos, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Ainos, Inc. reported earnings per share of -$0.64.
Enterprise value:
18.3M
EV / Invested capital:
0.87x
Price / LTM sales:
174.92x
EV / EBIT:
--
EV / Revenue:
161.78x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-3.84x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.5M
Return On Assets:
-56.17%
Net Income Margin (TTM):
-13224.32%
Return On Equity:
-109.74%
Return On Invested Capital:
-59.16%
Operating Margin:
-126554.55%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1M | $40.6K | $113K | -- | $2.2K | |
| Gross Profit | -$4.5M | -$1.3M | -$3.5M | -$500 | -$1.2M | |
| Operating Income | -$9.6M | -$14.6M | -$14.3M | -$3M | -$2.8M | |
| EBITDA | -$4.8M | -$9.8M | -$9.6M | -$1.8M | -$1.6M | |
| Diluted EPS | -$2.48 | -$2.66 | -$3.35 | -$0.33 | -$0.64 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $884.8K | $3.7M | $3M | $5.6M | $1.7M | |
| Total Assets | $20M | $39.1M | $33.9M | $31.4M | $22.7M | |
| Current Liabilities | $2.8M | $2.6M | $819.5K | $4.1M | $581.4K | |
| Total Liabilities | $2.9M | $2.7M | $6.2M | $13.3M | $12.6M | |
| Total Equity | $17.1M | $36.4M | $27.7M | $18M | $10M | |
| Total Debt | $35.3K | $12.5K | $5.3M | $9M | $11M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.9M | -$6.3M | -$4.6M | -$1.5M | -$1.2M | |
| Cash From Investing | -$82.6K | -$122.6K | $200 | -$18.8K | $4.9K | |
| Cash From Financing | $4M | $9.2M | $582.6K | -$1.5M | $1.1M | |
| Free Cash Flow | -$4M | -$6.3M | -$4.8M | -$1.5M | -$1.2M | |
AIMD
Sector
Market Cap
$8.3M
$28.1M
Price % of 52-Week High
39.6%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-8.77%
-1.49%
1-Year Price Total Return
-14.47%
-17.13%
Beta (5-Year)
2.387
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.09
200-day SMA
Sell
Level
$2.94
Bollinger Bands (100)
Sell
Level
2.45 - 3.83
Chaikin Money Flow
Sell
Level
-94.3M
20-day SMA
Sell
Level
$2.16
Relative Strength Index (RSI14)
Sell
Level
37.65
ADX Line
Sell
Level
23.67
Williams %R
Buy
Level
-88.3392
50-day SMA
Sell
Level
$2.73
MACD (12, 26)
Sell
Level
-0.16
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
180.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.8133)
Sell
CA Score
(Annual)
Level (-1.7938)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (4.4317)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its medtech solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded on June 26, 1984 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, AIMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AIMD average analyst price target in the past 3 months is --.
-
Where Will Ainos, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ainos, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Ainos, Inc.?
Analysts are divided on their view about Ainos, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ainos, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Ainos, Inc.'s Price Target?
The price target for Ainos, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AIMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ainos, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AIMD?
You can purchase shares of Ainos, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ainos, Inc. shares.
-
What Is The Ainos, Inc. Share Price Today?
Ainos, Inc. was last trading at $1.98 per share. This represents the most recent stock quote for Ainos, Inc.. Yesterday, Ainos, Inc. closed at $1.98 per share.
-
How To Buy Ainos, Inc. Stock Online?
In order to purchase Ainos, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get AIMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AIMD
Sector
P/E ratio
--
23.89x
PEG ratio
-0.02x
-0.01x
P/B ratio
0.83x
1.81x
Price / LTM sales
174.92x
1.59x
Growth Metrics
AIMD
Sector
Revenue growth
412.36%
4.62%
Earnings growth
-96.25%
11.06%
Revenue (5-year growth)
12.06%
6.5%
Earnings forecast
--
-$0.21
Profitability
AIMD
Sector
Profitability FY 2024
-$4.8M
$3.6M
Return on invested capital
-59.16%
-31.84%
Return on assets
-56.17%
-27.96%
Return on equity
-109.74%
-37.63%
Earnings Date
Last Earnings Date
Dec
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
AIMD
Sector
Total cash
$1.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$28.8M
$76.9M
Long term debt
$11M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
